DWA

Douglass Winthrop Advisors Portfolio holdings

AUM $5.54B
This Quarter Return
+10.88%
1 Year Return
+21.18%
3 Year Return
+83.73%
5 Year Return
+139.67%
10 Year Return
+337.73%
AUM
$3.65B
AUM Growth
+$3.65B
Cap. Flow
+$18.8M
Cap. Flow %
0.52%
Top 10 Hldgs %
40.17%
Holding
249
New
6
Increased
58
Reduced
109
Closed
10

Sector Composition

1 Financials 23.34%
2 Technology 14.98%
3 Healthcare 12.72%
4 Industrials 12.09%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BP icon
126
BP
BP
$90.8B
$812K 0.02%
23,238
COR icon
127
Cencora
COR
$56.5B
$810K 0.02%
4,888
-12
-0.2% -$1.99K
APD icon
128
Air Products & Chemicals
APD
$65.5B
$801K 0.02%
2,600
-200
-7% -$61.6K
BX icon
129
Blackstone
BX
$134B
$772K 0.02%
10,410
AME icon
130
Ametek
AME
$42.7B
$769K 0.02%
5,503
-25
-0.5% -$3.49K
HSY icon
131
Hershey
HSY
$37.3B
$760K 0.02%
3,284
TFC icon
132
Truist Financial
TFC
$60.4B
$754K 0.02%
17,525
CVS icon
133
CVS Health
CVS
$92.8B
$736K 0.02%
7,901
+21
+0.3% +$1.96K
LH icon
134
Labcorp
LH
$23.1B
$728K 0.02%
3,090
GILD icon
135
Gilead Sciences
GILD
$140B
$723K 0.02%
8,425
+850
+11% +$72.9K
ISRG icon
136
Intuitive Surgical
ISRG
$170B
$699K 0.02%
2,634
NOW icon
137
ServiceNow
NOW
$190B
$699K 0.02%
1,800
-1,100
-38% -$427K
ELV icon
138
Elevance Health
ELV
$71.8B
$698K 0.02%
1,361
WFC icon
139
Wells Fargo
WFC
$263B
$698K 0.02%
16,900
RTX icon
140
RTX Corp
RTX
$212B
$695K 0.02%
6,884
-657
-9% -$66.3K
CL icon
141
Colgate-Palmolive
CL
$67.9B
$692K 0.02%
8,778
IDXX icon
142
Idexx Laboratories
IDXX
$51.8B
$691K 0.02%
1,693
CDW icon
143
CDW
CDW
$21.6B
$680K 0.02%
3,806
-100
-3% -$17.9K
DD icon
144
DuPont de Nemours
DD
$32.2B
$678K 0.02%
9,880
-1,558
-14% -$107K
CSX icon
145
CSX Corp
CSX
$60.6B
$673K 0.02%
21,716
+144
+0.7% +$4.46K
LOW icon
146
Lowe's Companies
LOW
$145B
$673K 0.02%
3,380
-231
-6% -$46K
SYK icon
147
Stryker
SYK
$150B
$668K 0.02%
2,734
OKE icon
148
Oneok
OKE
$48.1B
$657K 0.02%
10,000
UL icon
149
Unilever
UL
$155B
$637K 0.02%
12,655
-1,000
-7% -$50.3K
NVS icon
150
Novartis
NVS
$245B
$629K 0.02%
6,938
-800
-10% -$72.5K